6505NCM206417: ERYTHROMYCIN TABLETS.
The ERYTHROMYCIN TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, special_features: ERYTHROMYCIN STEARATE TABLETS 250 MG 30S. STORE BELOW 86 F (30 C)., primary_container_type: BOTTLE, total_primary_container_quantity: 30, primary_container_content_quantity: 30.0 TABLETS, active_medicament_medicinal_strength: 250.0 MILLIGRAMS ERYTHROMYCIN STEARATE ACTIVE INGREDIENT.
This part is cataloged in the U.S. Government catalog under NSN 6505-01-690-6271, indicating validated use in U.S. government and defense logistics supply chains.
Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | ERYTHROMYCIN STEARATE TABLETS 250 MG 30S. STORE BELOW 86 F (30 C). |
| primary_container_type | BOTTLE |
| total_primary_container_quantity | 30 |
| primary_container_content_quantity | 30.0 TABLETS |
| active_medicament_medicinal_strength | 250.0 MILLIGRAMS ERYTHROMYCIN STEARATE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | ERYTHROMYCIN STEARATE TABLETS 250 MG 30S |
| NSN | 6505-01-690-6271 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 30.0 TABLETS |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | ERYTHROMYCIN STEARATE TABLETS 250 MG 30S. STORE BELOW 86 F (30 C). |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ERYTHROMYCIN STEARATE TABLETS 250 MG 30S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.0 MILLIGRAMS ERYTHROMYCIN STEARATE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 30 |